Synonyms:5-Aminosalicylic acid, mesalamine, Mesalazine, 89-57-6, 5-Amino-2-hydroxybenzoic acid, Pentasa, Asacol, Canasa, 5-ASA, Claversal, Rowasa, Salofalk, m-Aminosalicylic acid, Lialda, Mesasal, Benzoic acid, 5-amino-2-hydroxy-, Fisalamine, Apriso, Lixacol, sfRowasa, p-Aminosalicylsaeure, Asacolitin, Mesalazina, Mesalazinum, Iialda, 5-amino-2-hydroxy-benzoic acid, Asacol HD, Mesalamine [USAN], 5-Amino Salicylic Acid, 2-Hydroxy-5-aminobenzoic acid, MAX-002, 3-carboxy-4-hydroxyaniline, SALICYLIC ACID, 5-AMINO-, MFCD00007877, NSC 38877, NSC-38877, Mesalazine [INN], MESALAMINE-D3, MLS001424012, 4Q81I59GXC, CHEBI:6775, DTXSID5024506, mesalamine (USAN), 5-?Aminosalicylic Acid (Mesalazine), CAS-89-57-6, NCGC00016344-03, Mesalazinum [Latin], SMR000145728, DTXCID804506, Mesalazina [Spanish], 1309283-32-6, p-Aminosalicylsaeure [German], Mesavancol, Delzicol, Mesavance, Mezavant, Mesalazine MMX, Mezavant XL, Mesalamine (USP), Pentasa (TN), Salofalk Granu-Stix, Apriso (TN), Asacol (TN), Canasa (TN), Lialda (TN), Rowasa (TN), 5-AS, CCRIS 7334, SR-01000763486, Mesalamine [USAN:USP], EINECS 201-919-1, BRN 2090421, UNII-4Q81I59GXC, AI3-15564, 5-Amino 2-hydroxy benzoic acid, HSDB 7512, AJG-501, SPD 476, SPD-476, SPD-480, Mesalamine (TN), Delzicol (TN), Sfrowasa (TN), Mesalamine (Lialda), 5-aminosalicylic_acid, MD-0901, 5-Aminosalicyclic acid, 5-amino-salicylic acid, MESALAMINE [MI], MESALAZINE [JAN], Prestwick0_001069, Prestwick1_001069, Prestwick2_001069, Prestwick3_001069, MESALAMINE [HSDB], WLN: ZR DQ CVQ, Z-206, MESALAMINE [VANDF], CHEMBL704, Mesalazine (JP17/INN), EC 201-919-1, cid_4075, MESALAZINE [MART.], MESALAMINE [USP-RS], MESALAZINE [WHO-DD], Oprea1_847633, SCHEMBL31297, 3amino-6-hydroxybenzoic acid, BSPBio_001058, KBioGR_002425, KBioSS_002431, 4-14-00-02058 (Beilstein Handbook Reference), MLS000758287, 5-Aminosalicylic acid, 95%, 5-Aminosalicylic acid, tablet, BIDD:GT0811, 3-amino-6-hydroxybenzoic acid, SPBio_002969, BPBio1_001164, GTPL2700, MESALAMINE [ORANGE BOOK], MESALAZINE [EP IMPURITY], SCHEMBL18038934, 5-Aminosalicylic acid, >=99%, BDBM60918, KBio2_002425, KBio2_004993, KBio2_007561, KBio3_002904, MESALAZINE [EP MONOGRAPH], cMAP_000045, HMS1571E20, HMS2051M21, HMS2090I09, HMS2098E20, HMS3393M21, HMS3649K15, HMS3651M15, HMS3715E20, MESALAMINE [USP MONOGRAPH], Pharmakon1600-01505993, BCP05326, NSC38877, Tox21_110384, Tox21_201610, Tox21_303125, AC8101, BBL013046, NSC759301, s1681, STK301678, AKOS000118959, Tox21_110384_1, AC-2764, BCP9000175, CCG-100829, DB00244, HS-0100, NC00079, NSC-759301, NCGC00016344-01, NCGC00016344-02, NCGC00016344-04, NCGC00016344-05, NCGC00016344-07, NCGC00090934-01, NCGC00090934-02, NCGC00257142-01, NCGC00259159-01, 5-amino-2-hydroxobenzoic acid monohydrate, 51481-17-5, BP-13074, HY-15027, SY002854, 5-Aminosalicylic acid, analytical standard, A0317, AB00374979, AM20060091, FT-0619950, SW197303-4, EN300-18389, C07138, D00377, AB00374979-09, AB00374979-10, AB00374979_11, AB00374979_12, Q412479, 5-amino-2-hydroxybenzoic acid,5-Aminosalicylic acid, Q-201355, SR-01000763486-3, SR-01000763486-4, SR-01000763486-9, Z57127471, F1918-0003, Mesalazine, European Pharmacopoeia (EP) Reference Standard, Mesalamine, United States Pharmacopeia (USP) Reference Standard, Mesalamine, Pharmaceutical Secondary Standard; Certified Reference Material, Mesalazine for system suitability, European Pharmacopoeia (EP) Reference Standard
Pubchem:PUBCHEM:4075
Id:434cc2f2-dad9-5635-a776-6aba504843ba
Description:nan
